Detection of COVID-19 Subjects Using DiaNose Exhalation Test
NCT04476927 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2020-07-20
Summary
The study aim is to collect and analyze data of potential Volatile Organic Compounds (VOCs) that could be used for discriminating between patients with and without COVID-19 or with high-risk for COVID-19 by DiaNose breath test.
up to 300 subjects will be enrolled to the study ( 200 COVID-19 suspected and 100 healthy volunteers in two clinical sites (1 in Israel and 1 in US).
DiaNose system is an electronic nose device that can "smell" diseases in the exhaled breath of patients in real time. This approach is non-invasive, simple and save.
The DiaNose prototype system consists the following elements:
A Soft Tube connected to a Sensors Chamber - The soft tube is made of medical grade silicon. The subject blows air into the tube for a few seconds and the exhaled air is directed through the sensors chamber. This unit is for single use.
• Sensors Reading Unit- a multi used unit for sensors signals measurement. The Sensor Reading Unit is connected to a Laptop that is used to activate and save the test measurements.
Conditions
Interventions
- DEVICE
-
DiaNose
DiaNose system is an electronic nose device that can "smell" diseases in the exhaled breath of patients in real time. The recognition of Volatile Organic Compounds (VOCs) in breath samples approach is non-invasive and for safe diagnosis of diseases. The DiaNose prototype system consists the following elements: * A Soft Tube connected to a Sensors Chamber - The soft tube is made of medical grade silicon. The subject blows air into the tube for a few seconds and the exhaled air is directed through the sensors chamber. This unit is for single use. * Sensors Reading Unit- a multi used unit for sensors signals measurement. The Sensor Reading Unit is connected to a Laptop either via a Data Acquisition Instrument - Commercial unit for resistance measurements (https://www.tek.com/keithley-switching-and-data-acquisition-systems/keithley-daq6510) (option A ) or directly by a USB cable (option B). * Laptop - Laptop is used to activate and save the test measurements.
Sponsors & Collaborators
-
Nanose Medical Ltd.
lead INDUSTRY
Principal Investigators
-
Ravit Peled · Nanose Medical
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2021-05-30
- Completion
- 2021-06-30
- FDA Device
- Yes
More Related Trials
-
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
NCT04305457 ·Status: TERMINATED ·Phase: PHASE2
-
Early Detection of COVID-19 Using Breath Analysis
NCT04602884 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources
NCT05196581 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19
NCT05279391 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19
NCT04681079 ·Status: COMPLETED
-
Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19)
NCT04594460 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia
NCT04445272 ·Status: COMPLETED ·Phase: PHASE2
-
Bioaerosol Sampling Device (BSD) Clinical Study
NCT06047067 ·Status: UNKNOWN
-
Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19
NCT05675072 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes
NCT04830020 ·Status: COMPLETED ·Phase: PHASE2
-
Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients
NCT04472728 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care
NCT05083000 ·Status: UNKNOWN ·Phase: PHASE1
-
Exhaled Breath Aerosol for the Etiological Diagnosis of Respiratory Tract Infections: a Pilot Study
NCT06229613 ·Status: COMPLETED
-
The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
NCT04312997 ·Status: COMPLETED ·Phase: PHASE2
-
Nasal Muco-ciliary Clearance Study With and Without Salt Inhalation
NCT04189016 ·Status: UNKNOWN ·Phase: NA
-
Study of F-652 in Subjects With Corona Virus Disease 2019 (COVID-19) Pneumonia
NCT05205668 ·Status: WITHDRAWN ·Phase: PHASE2
-
Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19
NCT04726098 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells
NCT04382547 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19
NCT05808400 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Hydrogen-Oxygen Generator With Nebulizer for Adjuvant Treatment of Novel Coronavirus Disease 2019 (COVID-19)
NCT05770206 ·Status: UNKNOWN ·Phase: NA
-
Safety and Pharmacokinetics of FBR-002 for the Treatment of Patients Hospitalized With COVID-19 in Need of Supplemental Oxygen and at Risk of Severe Outcome
NCT05279352 ·Status: UNKNOWN ·Phase: PHASE2
-
Inhaled Nitric Oxide for Preventing Progression in COVID-19
NCT04388683 ·Status: TERMINATED ·Phase: PHASE2
-
The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2
NCT04313023 ·Status: COMPLETED ·Phase: PHASE2
-
Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175
NCT05628740 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia
NCT04276987 ·Status: COMPLETED ·Phase: PHASE1